F. Martin

Immunology · Journal of Experimental Medicine · 2004–2012

A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 103 citations into it; #1,479 of 2,160 by trust here, #597 by citations

Whom F. Martin trusts

Their strongest outbound trust, strongest first, inferred from their citations.

1. Shimon Sakaguchi (in Immunology)

Who trusts F. Martin

1. L. Zitvogel (in Immunology)
2. Guido Kroemer (in Immunology)

Papers from F. Martin's perspective

Ordered by how strongly the researchers F. Martin trusts endorse each paper. Same corpus, a different order for every researcher.

1. Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells (Science)
2. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. (Journal of Clinical Investigation)
3. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival (Nature Medicine)
4. Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo (Nature Immunology)
5. Antigen-dependent Proliferation of CD4+ CD25+ Regulatory T Cells In Vivo (Journal of Experimental Medicine)
6. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. (Journal of Clinical Investigation)
7. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. (Blood)
8. Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells (Immunological Reviews)
9. Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants (Science)
10. Mechanisms and functional significance of tumour-induced dendritic-cell defects (Nature reviews. Immunology)

Their papers

• Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. (2010) — 959 citations
• Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth (2012) — 726 citations
• 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. (2010) — 1,247 citations
• Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients (2007) — 1,275 citations
• CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner (2005) — 877 citations
• Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4+CD25+ regulatory T cell proliferation (2005) — 824 citations
• CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative (2004) — 998 citations